Research & Literature

Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis.

Sposato LA, Cipriano LE, Saposnik G, et al.

The Lancet. Neurology 2015; (14(4)):377-87.

Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY).

Pathak RK, Middeldorp ME, Meredith M, et al.

Journal of the American College of Cardiology 2015; (65(20)):2159-69.

Comparison between radiofrequency with contact force-sensing and second-generation cryoballoon for paroxysmal atrial fibrillation catheter ablation: a multicentre European evaluation.

Squara F, Zhao A, Marijon E, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2015; (17(5)):718-24 doi:10.1093/europace/euv060.

Rate control versus rhythm control in atrial fibrillation: lessons learned from clinical trials of atrial fibrillation.

Waldo AL

Progress in cardiovascular diseases 2015; (58(2)):168-76.

Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.

Melgaard L, Gorst-Rasmussen A, Lane DA, et al.

JAMA 2015; (314(10)):1030-8 doi:10.1001/jama.2015.10725.

Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation: An Update.

Gutierrez A, Van Wagoner DR

Journal of cardiovascular pharmacology 2015; (66(6)):523-9 doi:10.1097/FJC.0000000000000313.

Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation.

Noseworthy PA, Yao X, Deshmukh AJ, et al.

Journal of the American Heart Association 2015; (4(11)).

Cardioversion in Non-Valvular Atrial Fibrillation.

Klein HH, Trappe HJ

Deutsches Arzteblatt international 2015; (112(50)):856-62.

Ischemic Stroke after Heart Transplantation.

Acampa M, Lazzerini PE, Guideri F, et al.

Journal of stroke 2016; (18(2)):157-68 doi:10.5853/jos.2015.01599.

Dronedarone: Basic Pharmacology and Clinical Use.

Tadros R, Nattel S, Andrade JG

Cardiac electrophysiology clinics 2016; (8(2)):453-65.

No Decline in the Risk of Stroke Following Incident Atrial Fibrillation Since 2000 in the Community: A Concerning Trend.

Chamberlain AM, Brown RD, Alonso A, et al.

Journal of the American Heart Association 2016; (5(6)).

Detection of Atrial Fibrillation with Intermittent Handheld Electrocardiogram in Patients with Ischemic Stroke and Transient Ischemic Attack.

Olsson AS, Engdahl J

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2016; (25(11)):2648-2652 doi:10.1016/j.jstrokecerebrovasdis.2016.07.010.

Rate control in atrial fibrillation.

Van Gelder IC, Rienstra M, Crijns HJ, Olshansky B

Lancet (London, England) 2016; (388(10046)):818-28.

Rhythm control in atrial fibrillation.

Piccini JP, Fauchier L

Lancet (London, England) 2016; (388(10046)):829-40.

Pulmonary Vein Antral Isolation and Nonpulmonary Vein Trigger Ablation Are Sufficient to Achieve Favorable Long-Term Outcomes Including Transformation to Paroxysmal Arrhythmias in Patients With Persistent and Long-Standing Persistent Atrial Fibrillation.

Liang JJ, Elafros MA, Muser D, et al.

Circulation. Arrhythmia and electrophysiology 2016; (9(11)).

Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial.

De Caterina R, Renda G, Carnicelli AP, et al.

Journal of the American College of Cardiology 2017; (69(11)):1372-1382 doi:10.1016/j.jacc.2016.12.031.

[Radiofrequency current or cryoballoon for ablation of atrial fibrillation? : Hot or cold?]

Reissmann B, Kuck KH, Metzner A

Herz 2017; (42(4)):352-356 doi:10.1007/s00059-017-4567-0.

Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.

Chao TF, Lip GYH, Liu CJ, et al.

Journal of the American College of Cardiology 2018; (71(2)):122-132 doi:10.1016/j.jacc.2017.10.085.

Catheter Ablation for Atrial Fibrillation with Heart Failure.

Marrouche NF, Brachmann J, Andresen D, et al.

The New England journal of medicine 2018; (378(5)):417-427 doi:10.1056/NEJMoa1707855.

Emergency medicine considerations in atrial fibrillation.

Long B, Robertson J, Koyfman A, et al.

The American journal of emergency medicine 2018; (36(6)):1070-1078 doi:10.1016/j.ajem.2018.01.066.

Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial.

Rienstra M, Hobbelt AH, Alings M, et al.

European heart journal 2018; (39(32)):2987-2996 doi:10.1093/eurheartj/ehx739.

Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?

Nielsen PB, Skjøth F, Overvad TF, et al.

Circulation 2018; (137(8)):832-840 doi:10.1161/CIRCULATIONAHA.117.029081.

Safety of Intravenous Diltiazem in Reduced Ejection Fraction Heart Failure with Rapid Atrial Fibrillation.

Jandali MB

Clinical drug investigation 2018; (38(6)):503-508 doi:10.1007/s40261-018-0631-7.

Associations of Obstructive Sleep Apnea With Atrial Fibrillation and Continuous Positive Airway Pressure Treatment: A Review.

Linz D, McEvoy RD, Cowie MR, et al.

JAMA cardiology 2018; (3(6)):532-540 doi:10.1001/jamacardio.2018.0095.

Practical Techniques in Cryoballoon Ablation: How to Isolate Inferior Pulmonary Veins.

Chen S, Schmidt B, Bordignon S, et al.

Arrhythmia & electrophysiology review 2018; (7(1)):11-17 doi:10.15420/aer.2018;1;2.

Detection of Subclinical Atrial Fibrillation in High-Risk Patients Using an Insertable Cardiac Monitor.

Philippsen TJ, Christensen LS, Hansen MG, et al.

JACC. Clinical electrophysiology 2017; (3(13)):1557-1564 doi:10.1016/j.jacep.2017.06.020.

Atrial fibrillation symptom clusters and associated clinical characteristics and outcomes: A cross-sectional secondary data analysis.

Streur M, Ratcliffe SJ, Callans D, et al.

European journal of cardiovascular nursing 2018; (17(8)):707-716 doi:10.1177/1474515118778445.

Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with bioprosthetic valves.

Andrade JG, Meseguer E, Didier R, et al.

Expert review of cardiovascular therapy 2018; (16(6)):413-418 doi:10.1080/14779072.2018.1475229.

Prognostic impact of digoxin use for rate control of atrial fibrillation in patients ≥75 years of age.

La Rovere MT, Traversi E

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2018; (88(2)):954 doi:10.4081/monaldi.2018.954.

PREVEntion and regReSsive Effect of weight-loss and risk factor modification on Atrial Fibrillation: the REVERSE-AF study.

Middeldorp ME, Pathak RK, Meredith M, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2018; (20(12)):1929-1935 doi:10.1093/europace/euy117.

Comparison of cryoballoon and radiofrequency ablation techniques for atrial fibrillation: a meta-analysis.

Maltoni S, Negro A, Camerlingo MD, et al.

Journal of cardiovascular medicine (Hagerstown, Md.) 2018; (19(12)):725-738 doi:10.2459/JCM.0000000000000725.

Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure.

Denham NC, Pearman CM, Caldwell JL, et al.

Frontiers in physiology 2018; (9()):1380 doi:10.3389/fphys.2018.01380.

A randomized clinical trial of early invasive intervention for atrial fibrillation (EARLY-AF) - methods and rationale.

Andrade JG, Champagne J, Deyell MW, et al.

American heart journal 2018; (206()):94-104 doi:10.1016/j.ahj.2018.05.020.

The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.

De Caterina R, Ageno W, Agnelli G, et al.

Thrombosis and haemostasis 2019; (119(1)):14-38 doi:10.1055/s-0038-1675816.

Catheter Ablation of Long-standing Persistent Atrial Fibrillation: a Reckless Challenge or a Way to Real Cure?

Pak HN

Korean circulation journal 2019; (49(2)):134-145 doi:10.4070/kcj.2018.0418.

Thyroid Function and Dysfunction in Relation to 16 Cardiovascular Diseases.

Larsson SC, Allara E, Mason AM, et al.

Circulation. Genomic and precision medicine 2019; (12(3)):e002468 doi:10.1161/CIRCGEN.118.002468.

Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.

Mark DB, Anstrom KJ, Sheng S, et al.

JAMA 2019; (321(13)):1275-1285 doi:10.1001/jama.2019.0692.

Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.

Packer DL, Mark DB, Robb RA, et al.

JAMA 2019; (321(13)):1261-1274 doi:10.1001/jama.2019.0693.

Chronic B-Type Natriuretic Peptide Therapy Prevents Atrial Electrical Remodeling in a Rabbit Model of Atrial Fibrillation.

Zhao H, Li T, Liu G, et al.

Journal of cardiovascular pharmacology and therapeutics 2019; (24(6)):575-585 doi:10.1177/1074248419854749.

Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.

Søndergaard L, Wong YH, Reddy VY, et al.

JACC. Cardiovascular interventions 2019; (12(11)):1055-1063 doi:10.1016/j.jcin.2019.04.004.

Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation.

Willems S, Meyer C, de Bono J, et al.

European heart journal 2019; (40(46)):3793-3799c doi:10.1093/eurheartj/ehz782.

The role of amiodarone in contemporary management of complex cardiac arrhythmias.

Mujović N, Dobrev D, Marinković M, et al.

Pharmacological research 2020; (151()):104521 doi:10.1016/j.phrs.2019.104521.

Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration.

Schnabel RB, Haeusler KG, Healey JS, et al.

Circulation 2019; (140(22)):1834-1850 doi:10.1161/CIRCULATIONAHA.119.040267.

Left atrial structure and function and the risk of death or heart failure in atrial fibrillation.

Inciardi RM, Giugliano RP, Claggett B, et al.

European journal of heart failure 2019; (21(12)):1571-1579 doi:10.1002/ejhf.1606.

Alcohol Abstinence in Drinkers with Atrial Fibrillation.

Voskoboinik A, Kalman JM, De Silva A, et al.

The New England journal of medicine 2020; (382(1)):20-28 doi:10.1056/NEJMoa1817591.

Comparison of Arrhythmia Detection by 24-Hour Holter and 14-Day Continuous Electrocardiography Patch Monitoring.

Chua SK, Chen LC, Lien LM, et al.

Acta Cardiologica Sinica 2020; (36(3)):251-259 doi:10.6515/ACS.202005_36(3).20190903A.

Balloon-Based Ablation Technologies.

Bhardwaj R, Neuzil P, Reddy VY, Dukkipati SR

Cardiac electrophysiology clinics 2020; (12(2)):175-185 doi:10.1016/j.ccep.2020.02.008.

Discontinuing Anticoagulation After Catheter Ablation of Atrial Fibrillation.

Pothineni NVK, Frankel DS

Cardiac electrophysiology clinics 2020; (12(2)):259-264 doi:10.1016/j.ccep.2020.02.007.

Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.

Osmancik P, Herman D, Neuzil P, et al.

Journal of the American College of Cardiology 2020; (75(25)):3122-3135 doi:10.1016/j.jacc.2020.04.067.

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.

Kirchhof P, Camm AJ, Goette A, et al.

The New England journal of medicine 2020; (383(14)):1305-1316 doi:10.1056/NEJMoa2019422.

Stroke prevention strategies in high-risk patients with atrial fibrillation.

Kotalczyk A, Mazurek M, Kalarus Z, et al.

Nature reviews. Cardiology 2021; (18(4)):276-290 doi:10.1038/s41569-020-00459-3.

Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation.

Wazni OM, Dandamudi G, Sood N, et al.

The New England journal of medicine 2021; (384(4)):316-324 doi:10.1056/NEJMoa2029554.

Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation.

Andrade JG, Wells GA, Deyell MW, et al.

The New England journal of medicine 2021; (384(4)):305-315 doi:10.1056/NEJMoa2029980.

Influence of Chronic Obstructive Pulmonary Disease on Atrial Mechanics by Speckle Tracking Echocardiography in Patients With Atrial Fibrillation.

Goedemans L, Leung M, van der Bijl P, et al.

The American journal of cardiology 2021; (143()):60-66 doi:10.1016/j.amjcard.2020.12.036.

External Cardiac Loop Recorders: Functionalities, Diagnostic Efficacy, Challenges and Opportunities.

Rajanna RR, Sriraam N, Prakash VS, et al.

IEEE reviews in biomedical engineering 2022; (15()):273-292 doi:10.1109/RBME.2021.3055219.

Clinical screening tools for obstructive sleep apnea in a population with atrial fibrillation: a diagnostic accuracy trial.

Mohammadieh AM, Sutherland K, Kanagaratnam LB, et al.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2021; (17(5)):1015-1024 doi:10.5664/jcsm.9098.

Atrial fibrosis and substrate based characterization in atrial fibrillation: Time to move forwards.

Quah JX, Dharmaprani D, Tiver K, et al.

Journal of cardiovascular electrophysiology 2021; (32(4)):1147-1160 doi:10.1111/jce.14987.

[Efficiency of the Decision-Making Module in the Personalized Choice of an Anticoagulant].

Gorbunova EV, Duvanova SP, Filimonov KM, et al.

Kardiologiia 2021; (61(3)):18-22 doi:10.18087/cardio.2021.3.n1511.

Prior ischemic strokes are non-inferior for predicting future ischemic strokes than CHA2DS2-VASc score in hemodialysis patients with non-valvular atrial fibrillation.

Bel-Ange A, Itskovich SZ, Avivi L, et al.

BMC nephrology 2021; (22(1)):179 doi:10.1186/s12882-021-02384-0.

Effect of Implantable vs Prolonged External Electrocardiographic Monitoring on Atrial Fibrillation Detection in Patients With Ischemic Stroke: The PER DIEM Randomized Clinical Trial.

Buck BH, Hill MD, Quinn FR, et al.

JAMA 2021; (325(21)):2160-2168 doi:10.1001/jama.2021.6128.

Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure.

Rillig A, Magnussen C, Ozga AK, et al.

Circulation 2021; (144(11)):845-858 doi:10.1161/CIRCULATIONAHA.121.056323.

Acute Consumption of Alcohol and Discrete Atrial Fibrillation Events.

Marcus GM, Vittinghoff E, Whitman IR, et al.

Annals of internal medicine 2021; (174(11)):1503-1509 doi:10.7326/M21-0228.

Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial.

Metzner A, Suling A, Brandes A, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2022; (24(4)):552-564 doi:10.1093/europace/euab200.

A Review of the Molecular Mechanisms Underlying Cardiac Fibrosis and Atrial Fibrillation.

Sygitowicz G, Maciejak-Jastrzębska A, Sitkiewicz D

Journal of clinical medicine 2021; (10(19)) doi:10.3390/jcm10194430.

Quality of life after the initial treatment of atrial fibrillation with cryoablation versus drug therapy.

Wazni O, Dandamudi G, Sood N, et al.

Heart rhythm 2022; (19(2)):197-205 doi:10.1016/j.hrthm.2021.10.009.

Efficacy of R2CHA2DS2-VA score for predicting thromboembolism in Thai patients with non-valvular atrial fibrillation.

Methavigul K, Sairat P, Krittayaphong R,

BMC cardiovascular disorders 2021; (21(1)):540 doi:10.1186/s12872-021-02370-2.

Diagnostic Yield, Outcomes, and Resource Utilization With Different Ambulatory Electrocardiographic Monitoring Strategies.

Gupta N, Yang J, Reynolds K, et al.

The American journal of cardiology 2022; (166()):38-44 doi:10.1016/j.amjcard.2021.11.027.

NICE atrial fibrillation guideline snubs wearable technology: a missed opportunity?

Briosa e Gala A, Pope MT, Leo M, et al.

Clinical medicine (London, England) 2022; (22(1)):77-82 doi:10.7861/clinmed.2021-0436.

Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease.

Fanaroff AC, Vora AN, Lopes RD

European heart journal supplements : journal of the European Society of Cardiology 2022; (24(Suppl A)):A19-A31 doi:10.1093/eurheartj/suab151.

Acute management of atrial fibrillation in congestive heart failure with reduced ejection fraction in the emergency department.

Hasbrouck M, Nguyen TT

The American journal of emergency medicine 2022; (58()):39-42 doi:10.1016/j.ajem.2022.03.058.

Perception of atrial fibrillation symptoms: Impact on quality of life and treatment in older adults.

Abu HO, Wang W, Otabil EM, et al.

Journal of the American Geriatrics Society 2022; (70(10)):2805-2817 doi:10.1111/jgs.17954.

Validation of Embolic and Bleeding Risk Scores in Patients With Atrial Fibrillation and Cancer.

Raposeiras-Roubin S, Abu-Assi E, Marchán A, et al.

The American journal of cardiology 2022; (180()):44-51 doi:10.1016/j.amjcard.2022.06.044.

Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial.

Eckardt L, Sehner S, Suling A, et al.

European heart journal 2022; (43(40)):4127-4144 doi:10.1093/eurheartj/ehac471.

Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study.

Lubitz SA, Faranesh AZ, Selvaggi C, et al.

Circulation 2022; (146(19)):1415-1424 doi:10.1161/CIRCULATIONAHA.122.060291.

Electrical, structural, and autonomic atrial remodeling underlies atrial fibrillation in inflammatory atrial cardiomyopathy.

Murakata Y, Yamagami F, Murakoshi N, et al.

Frontiers in cardiovascular medicine 2022; (9()):1075358 doi:10.3389/fcvm.2022.1075358.

Atrial Fibrillation and Diabetes Mellitus: Dangerous Liaisons or Innocent Bystanders?

Lorenzo-Almorós A, Casado Cerrada J, Álvarez-Sala Walther LA, et al.

Journal of clinical medicine 2023; (12(8)) doi:10.3390/jcm12082868.

The Liver-Heart Connection: A Literature Review of Liver Disease as a Risk Factor for Atrial Fibrillation.

Obi MF, Reinberg Palmar A, Namireddy V, et al.

Cureus 2023; (15(5)):e38536 doi:10.7759/cureus.38536.

Transesophageal Echocardiogram Before Cardioversion in Atrial Fibrillation Patients.

Adedara VO, Sharma V, Nawaz H, et al.

Cureus 2023; (15(5)):e39702 doi:10.7759/cureus.39702.

Dronedarone Versus Sotalol in Antiarrhythmic Drug-Naive Veterans With Atrial Fibrillation.

Pundi K, Fan J, Kabadi S, et al.

Circulation. Arrhythmia and electrophysiology 2023; (16(8)):456-467 doi:10.1161/CIRCEP.123.011893.

CLOSE-Guided Pulmonary Vein Isolation to Treat Persistent Atrial Fibrillation: 1-Year Outcome.

Taghji P, Deharo JC, Amraoui S, Bun SS

Journal of clinical medicine 2023; (12(14)) doi:10.3390/jcm12144698.

Pharmacological cardioversion of atrial fibrillation: practical considerations.

Wybraniec MT, Kampka Z, Mizia-Stec K

Polish archives of internal medicine 2023; (133(9)) doi:10.20452/pamw.16547.

Preceding Night Sleep Quality and Atrial Fibrillation Episodes in the I-STOP-AFIB Randomized Trial.

Wong CX, Modrow MF, Sigona K, et al.

JACC. Clinical electrophysiology 2024; (10(1)):56-64 doi:10.1016/j.jacep.2023.09.009.

2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

Joglar JA, Chung MK, Armbruster AL, et al.

Circulation 2024; (149(1)):e1-e156 doi:10.1161/CIR.0000000000001193.

Left atrial volume index: A predictor of atrial fibrillation recurrence following direct current cardioversion - A systematic review and meta-analysis.

Raniga D, Goda M, Hattingh L, et al.

International journal of cardiology. Heart & vasculature 2024; (51()):101364 doi:10.1016/j.ijcha.2024.101364.

Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients.

Serna MJ, Rivera-Caravaca JM, López-Gálvez R, et al.

Revista espanola de cardiologia (English ed.) 2024; (77(10)):835-842 doi:10.1016/j.rec.2024.02.011.

Pathophysiology and clinical relevance of atrial myopathy.

Tubeeckx MRL, De Keulenaer GW, Heidbuchel H, Segers VFM

Basic research in cardiology 2024; (119(2)):215-242 doi:10.1007/s00395-024-01038-0.

Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database.

Truong B, Hornsby L, Fox B, et al.

Journal of thrombosis and thrombolysis 2024; (57(4)):638-649 doi:10.1007/s11239-024-02958-3.

Assessing the impact of atrial fibrillation self-care interventions: A systematic review.

Wilson RE, Burton L, Marini N, et al.

American heart journal plus : cardiology research and practice 2024; (43()):100404 doi:10.1016/j.ahjo.2024.100404.

Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS).

Goette A, Corradi D, Dobrev D, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2024; (26(9)) doi:10.1093/europace/euae204.

Assessing Stroke and Mortality Risk in Heart Failure: The CHA2DS2-VASc Score's Prognostic Value in Patients With and Without Atrial Fibrillation: A Meta-Analysis.

Abouzid MR, Kamel I, Saleh A, et al.

Cardiology in review 2024; doi:10.1097/CRD.0000000000000749.

Amiodarone Therapy: Updated Practical Insights.

Șorodoc V, Indrei L, Dobroghii C, et al.

Journal of clinical medicine 2024; (13(20)) doi:10.3390/jcm13206094.

[The 2024 ESC guidelines for management of atrial fibrillation : AF-CARE as new credo].

Wolfes J, Eckardt L

Herzschrittmachertherapie & Elektrophysiologie 2024; (35(4)):318-323 doi:10.1007/s00399-024-01053-7.

Characteristics of Patients With Asymptomatic Atrial Fibrillation and Ischemic Stroke-Insights From the GLORIA-AF Registry (Phase 2).

Heer T, Zeymer U, Schwarzbach CJ, et al.

Pacing and clinical electrophysiology : PACE 2025; (48(1)):42-49 doi:10.1111/pace.15113.

[European Society of Cardiology (ESC) guidelines on atrial fibrillation 2024 : What is new and what is important?]

Hättasch R, Tscholl V, Hindricks G, Dagres N

Herz 2025; (50(1)):3-7 doi:10.1007/s00059-024-05287-6.

Prevalence of asymptomatic atrial fibrillation and risk factors associated with asymptomatic status: a systematic review and meta-analysis.

Pamporis K, Karakasis P, Sagris M, et al.

European journal of preventive cardiology 2025; doi:10.1093/eurjpc/zwaf138.

Association between left atrial slow conduction velocity and recurrence of atrial fibrillation: a prospective study based on high-density mapping.

Qi D, Guan X, Liu X, et al.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing 2025; (68(9)):1813-1822 doi:10.1007/s10840-025-02052-5.

Multifactorial Risk Stratification in Patients with Heart Failure, Chronic Kidney Disease, and Atrial Fibrillation: A Comprehensive Analysis.

Iacob MS, Kundnani NR, Sharma A, et al.

Life (Basel, Switzerland) 2025; (15(5)) doi:10.3390/life15050786.

Atrial fibrosis in atrial fibrillation: Mechanisms, mapping techniques and clinical applications.

Horrach CV, Bevis L, Nwanna C, et al.

The Journal of physiology 2026; (604(13)):5103-5125 doi:10.1113/JP288680.

Timing of stroke risk reassessment in atrial fibrillation patients with a CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study.

Anjum M, Ariansen I, Myrstad M, et al.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2025; (27(10)) doi:10.1093/europace/euaf145.

[Update of the ESC atrial fibrillation guidelines : From the DGK commission for clinical cardiovascular medicine].

Schnabel RB, Gunawardene MA, Perings CA, et al.

Herzschrittmachertherapie & Elektrophysiologie 2025; (36(3)):226-232 doi:10.1007/s00399-025-01096-4.

Left Atrial Appendage Occlusion Devices Focused on Complications of Therapy.

Castillo-Rodriguez C, Salguero D, Cruz D, et al.

Cardiology in review 2025; doi:10.1097/CRD.0000000000001035.

Current risk stratification schemes for preventing ischemic stroke in patients with nonvalvular atrial fibrillation: HELT-E2S2 and CHA2DS2-VA scores.

Tomita H, Okumura K

Journal of cardiology 2026; (87(2)):136-143 doi:10.1016/j.jjcc.2025.10.005.

Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation: who should receive it in current clinical practice?

d'Entremont MA, Healy JS, Jolly SS

Current opinion in cardiology 2026; (41(1)):10-15 doi:10.1097/HCO.0000000000001270.

Atrial fibrillation and primary care prevention and rehabilitation - a feasibility study.

Elnegaard CM, Pedersen MK, Zwisler AO, et al.

Pilot and feasibility studies 2025; (11(1)):150 doi:10.1186/s40814-025-01724-3.

Comparison of non-dihydropyridine calcium channel blockers with beta blockers as treatment for atrial fibrillation: protocol for a systematic review with meta-analysis.

Koldenhof T, Gareb B, Smit MD, et al.

Systematic reviews 2026; (15(1)):44 doi:10.1186/s13643-025-03035-3.

New recommendations for rhythm control-What has changed in the 2023 ACC/AHA/ACCP/HRS and 2024 ESC guidelines for atrial fibrillation, and where does dronedarone fit in?

Naccarelli GV, Rackley J, Boriani G

American heart journal plus : cardiology research and practice 2025; (60()):100645 doi:10.1016/j.ahjo.2025.100645.

Patient-Led Smartwatch ECG Follow-Up Strategy After AF Ablation: Clinical Trial Design and Implementation.

Ahluwalia N, Abbass H, Hussain A, et al.

JACC. Advances 2026; (5(2)):102534 doi:10.1016/j.jacadv.2025.102534.

Inflammatory pathways in atrial fibrillation: mechanisms and novel therapeutic targets.

Lu YY, Chen YJ, Lip GYH, Chen SA

European heart journal 2026; (47(23)):2894-2912 doi:10.1093/eurheartj/ehag131.

Exercise capacity and quality-of-life improvements after catheter ablation in patients with clinically asymptomatic persistent atrial fibrillation.

Fujisawa T, Kawakami H, Kurokawa K, et al.

Heart rhythm 2026; (23(7)):e1000-e1011 doi:10.1016/j.hrthm.2026.03.1947.

Intraprocedural atrial flutter transition predicts arrhythmia-free survival after "2C3L Plus" ablation for long-standing persistent atrial fibrillation.

Liu T, Han K, Yang Y, Long D

Frontiers in cardiovascular medicine 2026; (13()):1781094 doi:10.3389/fcvm.2026.1781094.

Utility of Risk Scores for Predicting Stroke and Intracranial Bleeding Across Levels of Kidney Function in Two Large Community-Based Cohorts of Older Adults With Atrial Fibrillation.

Bansal N, Tabada GH, Kang Y, et al.

American journal of kidney diseases : the official journal of the National Kidney Foundation 2026; (88(3)):341-355 doi:10.1053/j.ajkd.2026.03.038.

[Position paper of the German Society of Cardiology-quality criteria for performing catheter ablation of atrial fibrillation: executive summary].

Steven D, Chun J, Deisenhofer I, et al.

Herzschrittmachertherapie & Elektrophysiologie 2026; (37(2)):229-238 doi:10.1007/s00399-026-01149-2.

When Rhythm Control Backfires: Flecainide-Precipitated Transient Cardiomyopathy in the Setting of Electrical Cardioversion.

Pagan Morales K, Shah D, Feldman D

Cureus 2026; (18(5)):e108713 doi:10.7759/cureus.108713.